<DOC>
	<DOCNO>NCT00259090</DOCNO>
	<brief_summary>To compare anti-tumour effect measure change various biomarkers , combination Faslodex Arimidex Faslodex alone Arimidex alone postmenopausal woman patient primary breast cancer await curative-intent surgery .</brief_summary>
	<brief_title>Anti-tumour Effects &amp; Tolerability Faslodex Alone Combination With Arimidex Post Menopausal Women Prior Surgery Primary Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<mesh_term>Fulvestrant</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<criteria>Postmenopausal woman . Biopsy confirmation primary breast cancer . Oestrogen receptor positive tumour . Fit surgery within one month . Written inform consent participate study Previous treatment antihormonal therapy breast cancer . Previous radiotherapy primary tumour . Previous chemotherapy primary tumour .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>